Changes in serum and tissue zinc levels in sex hormone-induced prostatic carcinogenesis in the noble rat

Tumor Biology

Volumn 21, Issue 6, 2000, Pages 328-336

  Wong, Y C ^a   Wang, Y Z ^a   Lee, J S K ^b   Tam, Neville N C ^a   Lee, Davy ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Prostate carcinogenesis; Serum zinc; Sex hormones; Tissue zinc

Indexed keywords

ESTRADIOL; SEX HORMONE; TESTOSTERONE; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL HETEROGENEITY; CONTROLLED STUDY; DRUG TISSUE LEVEL; DYSPLASIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; RAT; ZINC BLOOD LEVEL;

EID: 0033803756     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030138     Document Type: Article

References (20)

1. Fair WR, Wehner N: The prostatic antibacterial factor: Identity and significance; in Marberger H, et al (eds): Prostatic Disease. New York, Liss, 1976, vol 6.
2. Rosoff B: Studies of zinc in normal and neoplastic prostatic tissues: in Murphy GP, Sandberg AA, Kerr JP (eds): The Prostatic Cell: Structure and Function (pt A). New York, Liss, 1981, pp 447-457.
3. Liu Y, Franklin RB, Costello LC: Prolactin and testosterone regulation of mitochondrial zinc in prostate epithelial cells. Prostate 1997; 30:26-32.
4. Carpino A, Sisci D, Aquila S, Salerno M, Siciliano L, Sessa M, Ando S: Adnexal gland secretion markers in unexplained asthenozoospermia. Arch Androl 1994;32:37-43.
5. Costello LC, Franklin RB: Aconitase activity, citrate oxidation and zinc inhibition in rat ventral prostate. Enzyme 1981;26:281-287.
6. Costello LC, Franklin RB: Concepts of citrate production and secretion by prostate. 1. Metabolic relationships. Prostate 1991;18:25-46.
7. Hanas JS, Hazuda DJ, Bogenhagen DF, Wu FY, Wu CW: Xenopus transcription factor A requires zinc for binding to the 5 S RNA gene. J Biol Chem 1983;258:14120-14125.
8. Habib FK, Mason MK, Smith PH, Stitch SR: Cancer of the prostate: Early diagnosis by zinc and hormone analysis? Br J Cancer 1979; 39:700-704.
9. Dutkiewicz S: Zinc and magnesium serum levels in patients with benign prostatic hyperplasia (BPH) before and after prazosin therapy. Mater Med Pol 1995;27:15-17.
10. Wang YZ, Wong YC: Sex hormone-induced prostatic carcinogenesis in the Noble rat: The role of insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) in the development of prostate cancer. Prostate 1998;35:165-177.
11. Bedwal RS, Bahuguna A: Zinc, copper and selenium in reproduction. Experientia 1994;50:626-640.
12. Zhang XH, Jin L, Takenaka I: Localization of zinc and metallothionein in the rat bladder epithelium during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol Res 1996;24:279-283.
13. Zhang XH, Jin L, Sakamoto H, Takenaka I: Immunohistochemical localization of metallothionein in human prostate cancer. J Urol 1996; 156:1679-1681.
14. Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P, Bellocq JP, Rio MC: Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications. Matrix Biol 1997;15:535-541.
15. Abbasi AA, Prasad AS, Rabbani P, DuMouchelle E: Experimental zinc deficiency in man. Effect on testicular function. J Lab Clin Med 1980; 96:544-550.
16. Evans RM, Hollenberg SM: Zinc fingers: Guilt by association. Cell 1988;52:1-3.
17. Berg JM: Proposed structure for the zinc-binding domains from transcription factor IIIA and related proteins. Proc Natl Acad Sci USA 1988; 85:99-102.
18. Yucel I, Arpaci E, Ozet A, Doner B, Karayilanoglu T, Sayar A, Berk O: Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer. Biol Trace Elem Res 1994;40:31-38.
19. Pramoolsinsap C, Promvanit N, Komindr S, Lerdverasirikul P, Srianujata S: Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand. J Gastroenterol 1994;29:610-615.
20. Oyama T, Matsuno K, Kawamoto T, Mitsudomi T, Shirakusa T, Kodama Y: Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer. Biol Trace Elem Res 1994;42:115-127.